Acorda Therapeutics has a total of 1670 patents globally, out of which 752 have been granted. Of these 1670 patents, more than 47% patents are active. The United States of America is where Acorda Therapeutics has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of Acorda Therapeutics.
Acorda Therapeutics was founded in 1995 by Ron Cohen. Acorda Therapeutics is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain. As of July 2022, Acorda Therapeutics has a market cap of $5.90 Million.
Do read about some of the most popular patents of Acorda Therapeutics which have been covered by us in this article and also you can find Acorda Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Acorda Therapeutics patent portfolio.
How many patents does the Founder and CEO of Acorda Therapeutics have?
The Founder and CEO Ron Cohen have 219 patents.
How many patents does Acorda Therapeutics have?
Acorda Therapeutics has a total of 1670 patents globally. These patents belong to 240 unique patent families. Out of 1670 patents, 796 patents are active.
How Many Patents did Acorda Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Acorda Therapeutics Applications Filed||Acorda Therapeutics Patents Granted|
How many Acorda Therapeutics patents are Alive/Dead?
How Many Patents did Acorda Therapeutics File in Different Countries?
Countries in which Acorda Therapeutics Filed Patents
|United States Of America||329|
|Hong Kong (S.A.R.)||70|
|Yugoslavia/Serbia and Montenegro||1|
Where are Research Centers of Acorda Therapeutics Patents Located?
10 Best Acorda Therapeutics Patents
US6514482B1 is the most popular patent in the Acorda Therapeutics portfolio. It has received 360 citations so far from companies like Molex Incorporated, Topconn Electronic and Te Connectivity Corporation.
Below is the list of 10 most cited patents of Acorda Therapeutics:
|Publication Number||Citation Count|
What Percentage of Acorda Therapeutics US Patent Applications were Granted?
Acorda Therapeutics (Excluding its subsidiaries) has filed 214 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 124 have been granted leading to a grant rate of 61.6%.
Below are the key stats of Acorda Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Acorda Therapeutics?
|Law Firm||Total Applications||Success Rate|
|Morrison & Foerster Llp||38||74.29%|
|Troutman Pepper Hamilton Sanders Llp||33||75.00%|
|Norton Rose Fulbright Us Llp||27||92.59%|
|Mintz Levin Boston Office||23||69.57%|
|Elmore Patent Law Group Pc||19||73.33%|
|Hoffmann & Baron Llp||13||75.00%|
|Myers Bigel Pa||3||0.00%|
|David A Jackson Esq||2||0.00%|
|Finnegan Henderson Farabow Garrett & Dunner||2||0.00%|
EXCLUSIVE INSIGHTS COMING SOON!